Supernus Pharmaceuticals, Inc. company logo
Supernus Pharmaceuticals, Inc. logo

Supernus Pharmaceuticals, Inc. (SUPN) EBITDA

Annual EBITDA

$178.28M$88.24M+98.00%

Summary

Current Value
As of today, SUPN annual EBITDA is $178.28M, up +98.00% on
Historical Performance
SUPN annual EBITDA is up +38.00% over the past 3 years, and up +0.81% over the past 5 years
All-Time High Comparison
SUPN annual EBITDA is currently -15.32% below its historical high of $210.54M set on
3-Year Low Comparison
SUPN annual EBITDA is +98.00% above its 3-year low of $90.04M reached on
Sector Comparison
SUPN annual EBITDA is higher than 87.96% of companies in Healthcare sector

EBITDA Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

SUPN Performance
MetricDateValue1Y3Y5Y15Y
Annual EBITDA$178.28M+98.0%+38.0%+0.8%+3322.0%
Quarterly EBITDA-$36.21M-160.4%-274.6%-156.2%
TTM EBITDA$52.45M-66.4%-51.7%-73.3%
Price$51.24+36.9%+30.1%+92.9%
PE Ratio-
Annual Revenue$661.82M+8.9%+14.2%+68.5%+1645.1%
Annual EPS$1.32+5469.6%+34.3%-37.2%+1162.8%
Annual EBIT$97.87M+1787.9%+1.3%-42.5%+2265.2%
Annual Net Income$73.87M+5512.8%+38.3%-34.7%+1685.0%

EBITDA Highs

SUPN Annual EBITDA Highs Comparison
PeriodHighDateCurrent
3Y$178.28Mat high
5Y$210.54MN/A-15.3%
All$210.54M-15.3%

EBITDA Lows

SUPN Annual EBITDA Lows Comparison
PeriodLowDateCurrent
3Y$90.04M+98.0%
5Y$90.04M+98.0%
All-$83.68M+313.1%

EBITDA History

YearValueChange
$178.28M+98.0%
$90.04M-41.3%
$153.36M+18.7%
$129.19M-38.6%
$210.54M+19.0%
$176.85M+7.0%
YearValueChange
$165.35M+49.9%
$110.32M+90.7%
$57.86M+185.0%
$20.30M+641.9%
-$3.75M-

FAQ

  • What is the current annual EBITDA of SUPN?

    As of today, SUPN annual EBITDA is $178.28M

  • What is 1-year change in SUPN annual EBITDA?

    SUPN annual EBITDA is up +98.00% year-over-year

  • What is 3-year change in SUPN annual EBITDA?

    SUPN annual EBITDA is up +38.00% over the past 3 years

  • How far is SUPN annual EBITDA from its all-time high?

    SUPN annual EBITDA is currently -15.32% below its historical high of $210.54M set on December 31, 2020

  • How does SUPN annual EBITDA rank versus sector peers?

    SUPN annual EBITDA is higher than 87.96% of companies in Healthcare sector

  • When is SUPN next annual earnings release?

    The next annual earnings release for SUPN is on

EBITDA Formula

EBITDA = + + +

Data Sources & References

  1. SUPN Official Website www.supernus.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1356576/000135657625000071/0001356576-25-000071-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1356576/000135657625000017/0001356576-25-000017-index.htm
  4. SUPN Profile on Yahoo Finance finance.yahoo.com/quote/SUPN
  5. SUPN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/supn